Skip to Content

Join the 'Norditropin FlexPro' group to help and get support from people like you.

Norditropin FlexPro News

Childhood 'Growth' Tests Not Always Necessary

Posted 6 Oct 2017 by

FRIDAY, Oct. 6, 2017 – Just because a child isn't growing or developing exactly like his or her peers doesn't mean a host of medical tests are in order. In fact, five medical tests commonly ordered for children who are short, overweight or showing signs of early puberty aren't always necessary. And, that's particularly true if youngsters are otherwise healthy, according to the American Academy of Pediatrics (AAP). The five tests include hormone tests, endocrine tests, vitamin D screening, thyroid or insulin tests for overweight children and thyroid ultrasounds for kids with an enlarged thyroid gland or autoimmune thyroid disease, the group noted. Doctors and their patients should carefully weigh the risks and benefits of these procedures, advised Dr. Paul Kaplowitz in an AAP news release. He's past chairperson of the AAP Section on Endocrinology. "As a pediatric endocrinologist, I've ... Read more

Related support groups: Genotropin, Humatrope, Saizen, Nutropin, Pediatric Growth Hormone Deficiency, Norditropin, Serostim, Nutropin AQ, Omnitrope, Diagnosis and Investigation, Sermorelin, Somatropin, Egrifta, Tev-Tropin, Geref, Growth Retardation, Protropin, Zomacton, Norditropin Nordiflex, Zorbtive

Growth Hormone May Lower Odds of Fractures in Older Women

Posted 27 Aug 2015 by

THURSDAY, Aug. 27, 2015 – Older women with osteoporosis could get lasting benefits from a few years on growth hormone, a new, small trial suggests. Researchers found that when women with the bone-thinning disease took growth hormone for three years, their fracture risk was still reduced seven years later. Before entering the study, 56 percent of the women had suffered a bone break; over the 10-year study period, 28 percent sustained a fracture. But the study, reported online Aug. 27 in the Journal of Clinical Endocrinology & Metabolism, only involved 55 women who used growth hormone. And experts said it is unlikely to become an approved treatment for osteoporosis any time soon. Still, the results are "pretty exciting," since they show a sustained effect on women's fracture risk, said Dr. Jerome Tolbert, an endocrinologist at Mount Sinai Beth Israel in New York City. "Osteoporosis is a ... Read more

Related support groups: Osteoporosis, Fosamax, Alendronate, Boniva, Fracture, bone, Reclast, Prevention of Osteoporosis, Actonel, Zometa, Aclasta, Genotropin, Zoledronic Acid, Humatrope, Ibandronate, Atelvia, Risedronate, Nutropin, Saizen, Norditropin, Nutropin AQ

Short Boys Three Times More Likely to Get Growth Hormone: Study

Posted 16 Jun 2015 by

TUESDAY, June 16, 2015 – Short boys are much more likely than short girls to receive growth hormones, a new study finds. Researchers examined the medical records of more than 283,000 children and teens in the United States and found that short boys were up to three times more likely than short girls to receive recombinant human growth hormone treatment. Specifically, males accounted for 74 percent of patients who received the hormone to treat idiopathic short stature – shortness due to an unknown cause. Among patients who received the hormone for any diagnoses, 66 percent were male. The biggest gender differences in treatment occurred around puberty, when less time remains to correct poor growth in children, the researchers noted. The findings were published online June 9 in the journal Scientific Reports. "Growth is an important sign of child health, so growth failure merits equal ... Read more

Related support groups: Genotropin, Humatrope, Pediatric Growth Hormone Deficiency, Nutropin, Saizen, Norditropin, Nutropin AQ, Omnitrope, Serostim, Somatropin, Tev-Tropin, Growth Hormone Reserve Test, Norditropin FlexPro, Norditropin Nordiflex, Growth Retardation, HumatroPen, Zomacton, Zorbtive, Nutropin Depot, Accretropin

Children Prescribed Growth Hormone May Face Stroke Risk Later: Study

Posted 13 Aug 2014 by

WEDNESDAY, Aug. 13, 2014 – Children who are prescribed human growth hormone may be at greater risk of a stroke in early adulthood than their peers are, a new study suggests. While the study raises important questions about the safety of human growth hormone treatments, the study's French researchers encouraged parents to discuss the pros and cons of treatment with their child's physician. "For children and adolescents currently on growth hormone treatment, the treatment should not be stopped, but the doctor prescribing the treatment should be consulted," said study author Dr. Joel Coste, head of the biostatistics and epidemiology unit at Hotel Dieu at the University of Paris. One expert agreed that the finding should give parents pause. "The study represents a kind of yellow light that should make people stop and think about [the potential risks]," said Dr. Rebecca Ichord, director of ... Read more

Related support groups: Genotropin, Humatrope, Pediatric Growth Hormone Deficiency, Nutropin, Saizen, Norditropin, Nutropin AQ, Omnitrope, Serostim, Somatropin, Tev-Tropin, Norditropin Nordiflex, Norditropin FlexPro, Zorbtive, Growth Retardation, Nutropin Depot, HumatroPen, Accretropin

Ask a Question

Further Information

Related Condition Support Groups

Adult Human Growth Hormone Deficiency, Pediatric Growth Hormone Deficiency, Short Stature for Age, Hypopituitarism, Turner's Syndrome, Prader-Willi Syndrome, AIDS Related Wasting, Cachexia, Idiopathic Short Stature, Burns, Nitrogen Retention, Growth Retardation - Chronic Renal Failure, Noonan's Syndrome, Short Bowel Syndrome

Norditropin FlexPro Patient Information at